超声联合微泡剂用于肿瘤治疗的研究进展  

Advance of research on ultrasound combined with microbubble contrast agent used in treatment of tumors

作　　者：翟琦[1] 吴巍[1] 

机构地区：[1]东南大学公共卫生学院,江苏南京210009

出　　处：《医学研究生学报》2006年第11期1032-1035,共4页Journal of Medical Postgraduates

基　　金：国家"十五"科技攻关计划基金资助项目(批准号:2004BA706B03-01);江苏省技术创新资助项目(批准号:苏教财[2005]110号)

摘　　要：近年来,超声联合微泡剂在肿瘤治疗中的作用成为新的研究热点。目前的研究表明,超声联合微泡剂在肿瘤治疗中显示出了巨大潜力,可作为一种无创的有效治疗手段。利用低功率超声辐射微泡栓塞新生血管治疗肿瘤应用前景广阔,而具有靶向性的药物施放、基因治疗及提高高强度聚焦超声(H IFU)疗效等的基础研究,亦有望取得突破性进展。In recent years , the effects of ultrasound combined with microbubble contrast agent in treatment of tumors has been become a new research hot point, which may have great potential in tumor treatment. Low-power ultrasound radiating microbubble embolization angiogenesis therapeutics has been widely used in tumor treatment. Among them the following foundation research aspects can make great breakthrough,such as ： target drug delivery, target gene therapy, increasing high-intensity focused ultrosound therapy efficiency etc.

关 键 词：超声 微泡剂 肿瘤 

分 类 号：R730.58[医药卫生—肿瘤]